Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Mice Model Market analysis
Part of: Mice Model Market (Global)

The Europe Mice Model Market was valued at $1.29 Million in 2025 and projected to reach to $1.64 Million by 2030, representing a compound annual growth rate of 4.9%. Europe's mice model market is positioned for sustained growth, supported by established pharmaceutical and biotechnology sectors across major economies.

Europe Mice Model Market Trends and Insights

  • Other GCC Countries represents a developing segment within the broader GCC region, driven by increasing investment in biomedical research and pharmaceutical development.
  • The 4.9% compound annual growth rate reflects growing adoption of preclinical research models across academic institutions and contract research organizations in Other GCC Countries. Other GCC Countries' mice model market is supported by rising healthcare expenditure and regional initiatives to establish research infrastructure.
  • Between 2025 and 2030, Other GCC Countries is expected to see enhanced demand for genetically modified and disease models as local pharmaceutical companies expand R&D capabilities.
  • The market growth in Other GCC Countries, though moderate compared to global benchmarks, underscores the region's commitment to advancing life sciences research and reducing dependency on imported research models..

Key Market Statistics

  • CAGR (2025-2030) 4.9% CAGR
  • Market Size, 2025 ~USD 1.29 Million
  • Forecast, 2030 ~USD 1.64 Million
  • Geography Europe

Europe Mice Model Market Overview

Leading European Markets :

Germany and the UK dominate Europe's mice model market with combined market sizes of $275.3 million, driven by robust pharmaceutical R&D infrastructure and regulatory support for preclinical testing.

Steady Regional Growth :

Europe's mice model market is projected to grow at 4.9% CAGR from 2025 to 2030, reflecting consistent investment in biomedical research and drug development across the continent.

Research Hub Expansion :

France and Italy contribute $122.4 million combined, supported by strong academic institutions and government funding for life sciences research initiatives.

Emerging Opportunities :

Spain and Rest of Europe markets show growth potential as emerging biotech hubs increase demand for preclinical models and contract research services.

Europe Mice Model Market Dynamics

  • Germany, the UK, and France lead the region with significant investments in drug discovery and development.
  • The 4.9% CAGR reflects Europe's commitment to advancing biomedical research while maintaining stringent regulatory standards.
  • Increasing collaboration between academic institutions and industry players is driving demand for high-quality preclinical models.
  • The market benefits from Europe's strong intellectual property framework and government support for life sciences innovation, positioning the region as a critical hub for global pharmaceutical development..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Other GCC Countries' mice model market is valued at $1.29 million in 2025 and is forecast to reach $1.64 million by 2030.
    • The market in Other GCC Countries is growing at a CAGR of 4.9%, reflecting steady but measured expansion in preclinical research demand.
    • Other GCC Countries is investing in local research infrastructure and pharmaceutical R&D capabilities to drive market adoption.
    • Disease models and genetically modified mice are emerging as key growth drivers in Other GCC Countries' market between 2025 and 2030.

    Mice Model Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SERVICES (Model Type & Service)
    Forecast Period 2025–2030
    Growth Rate CAGR of 10% from 2025 to 2030
    Largest Segment MODEL TYPE (Model Type & Service)
    Market Size Base Year (Billions) ~USD 1.7 (2025)
    Revenue Forecast (Billions) ~USD 2.74 (2030)
    Segments Covered Model Type & Service, Type, Technology, Application, Therapeutic Area

    Europe Mice Model Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Model Type & Service

    • Model Type
    • Services

    By Type

    • Breeding Services
    • Cryopreservation Services
    • Genetically Engineered Mice
    • Hybrid/Congenic Mice
    • Inbred Mice
    • Other Services
    • Outbred Mice
    • Quarantine Services
    • Rederivation Services

    By Technology

    • Crispr/Cas9
    • Embryonic Stem Cell Injections
    • Microinjections
    • Nuclear Transfer Technique
    • Other Technologies

    By Application

    • Drug Discovery & Development
    • Personalized Medicine
    • Research Applications

    By Therapeutic Area

    • Cardiovascular Diseases
    • Immunology
    • Metabolic Diseases
    • Neurology
    • Oncology
    • Other Therapeutic Areas

    Target Audience

    • Pharmaceutical Companies : European and global pharma firms need market intelligence to optimize preclinical research investments, identify partnership opportunities, and plan European expansion strategies.
    • Biotech & CRO Organizations : Contract research organizations and biotech firms require detailed market data to assess European demand for mice models, benchmark services, and capture growth opportunities.
    • Research Institutions : Academic and government research centers need market insights to secure funding, justify procurement decisions, and understand competitive positioning in European research ecosystems.
    • Investors & Venture Capitalists : Investment firms evaluating European life sciences opportunities require comprehensive market analysis to identify high-growth segments and assess portfolio company potential.
    • Regulatory & Policy Bodies : European regulatory agencies and policy makers need market data to inform research funding decisions, regulatory frameworks, and support for biomedical innovation initiatives.

    Key Companies in the Europe Mice Model Market

    CompanyHQOwnershipStrongest segments
    HORIZON DISCOVERY GROUP PLCUnited KingdomPrivate CompanyScreening,Research Reagents,Diagnostics,
    LABORATORY CORPORATION OF AMERICA HOLDINGSUnited StatesPublic CompanyRoutine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D),
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyDiscovery and Safety Assessment,Research Models and Services,Manufacturing Solutions,
    THE JACKSON LABORATORYUnited StatesFoundation/Charitable InstitutionMouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models,
    INOTIVUnited StatesPublic CompanyResearch Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
    JSR CORPORATIONJapanPrivate CompanyDigital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support),
    BIOCYTOGENChinaPublic CompanyGene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales),
    SHANGHAI MODEL ORGANISMS CENTER, INC.ChinaPublic CompanyStandard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis),
    TRANS GENIC INC.JapanPublic CompanyDrug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis,
    HARBOUR BIOMEDChinaPublic CompanyHarbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio),
    GENOWAYFrancePublic CompanyCustom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom),
    GEMPHARMATECHChinaPublic CompanyStandard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services,
    VIVO BIO TECH LTD.IndiaPublic CompanyIn vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services,

    HORIZON DISCOVERY GROUP PLC

    Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.

    LABORATORY CORPORATION OF AMERICA HOLDINGS

    Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.

    THE JACKSON LABORATORY

    The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.

    INOTIV

    Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.

    JSR CORPORATION

    JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.

    BIOCYTOGEN

    Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.

    SHANGHAI MODEL ORGANISMS CENTER, INC.

    Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.

    TRANS GENIC INC.

    Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.

    HARBOUR BIOMED

    Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.

    GENOWAY

    Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.

    GEMPHARMATECH

    GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.

    VIVO BIO TECH LTD.

    Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 24.1 Million · 6% wtd CAGR ·
    North America
    ~USD 3.7 Million · 5.6% wtd CAGR ·
    Asia Pacific
    ~USD 12.57 Million · 5.4% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 132.2 Million
    UKUSD 143.1 Million
    FranceUSD 75.3 Million
    ItalyUSD 47.1 Million
    SpainUSD 31.7 Million
    Rest Of EuropeUSD 2 Million

    Country market size visualization

    Germany
    USD 132.2 Million
    UK
    USD 143.1 Million
    France
    USD 75.3 Million
    Italy
    USD 47.1 Million
    Spain
    USD 31.7 Million
    Rest Of Europe
    USD 2 Million

    Reasons to Buy this Report

    • Market Size & Growth Data : Access detailed market valuations for all major European countries including Germany ($132.2M), UK ($143.1M), and France ($75.3M) with accurate 4.9% CAGR projections through 2030.
    • Competitive Landscape Analysis : Understand market dynamics across Europe's leading pharmaceutical and biotech hubs to identify investment opportunities and competitive positioning strategies.
    • Regional Expansion Strategy : Develop targeted go-to-market strategies for emerging European markets like Spain and Italy with actionable insights on growth drivers and market entry barriers.
    • Regulatory & Investment Insights : Gain intelligence on European regulatory frameworks, government funding initiatives, and academic-industry partnerships shaping preclinical research demand.
    • Forecast Planning : Leverage 5-year market forecasts to 2030 for strategic planning, resource allocation, and revenue projections across European markets.

    Frequently asked questions

    What is the current market size of mice models in Other GCC Countries?

    The mice model market in Other GCC Countries is estimated at $1.29 million in 2025.

    What is the projected market size for Other GCC Countries by 2030?

    Other GCC Countries' mice model market is forecast to reach $1.64 million by 2030.

    What is the CAGR for the mice model market in Other GCC Countries?

    The market in Other GCC Countries is growing at a compound annual growth rate of 4.9% from 2025 to 2030.

    What factors are driving growth in Other GCC Countries' mice model market?

    Growth in Other GCC Countries is driven by increased pharmaceutical R&D investment, expanding research infrastructure, and rising demand for preclinical testing models.

    Which segments are most important in Other GCC Countries' mice model market?

    Disease models and genetically modified mice represent the most significant segments driving expansion in Other GCC Countries' market.

    RESEARCH METHODOLOGY

    This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    The following is a breakdown of the primary respondents:

    Mice Model Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Mice Model Market

    Data Triangulation

    The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.

    Stakeholders

    • Manufacturers & Distributors of Mice Models
    • CROs & CDMOs
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Market Research & Consulting Firms
    • Researchers & Scientists
    • Regulatory Authorities & Institutes

    Report Objectives

    • To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
    • To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
    • To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.

     

    Get the Full Mice Model Market Report

    Full forecast, segment splits, and company analysis for all Mice Model Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status